Quantum-Si, biotech stock near pivot
Quantum-Si 
QSI, develops access to the proteome with single-molecule analysis and democratizing to researchers & clinicians
Also, "is the world’s first-to-market provider of protein sequencing instruments with core technology based on proprietary time-domain sequencing that enables resolution of amino acids during experiments".- Ark Invest
The stock is near finalizing its bottoming process with a pivot buy at $2.50
The Biotech ETF
XBI already broke out so QSI is no leader, but still is a good set up.
QSI, develops access to the proteome with single-molecule analysis and democratizing to researchers & cliniciansAlso, "is the world’s first-to-market provider of protein sequencing instruments with core technology based on proprietary time-domain sequencing that enables resolution of amino acids during experiments".- Ark Invest
The stock is near finalizing its bottoming process with a pivot buy at $2.50
The Biotech ETF
XBI already broke out so QSI is no leader, but still is a good set up.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。